GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stenocare AS (OCSE:STENO) » Definitions » Selling, General, & Admin. Expense

Stenocare AS (OCSE:STENO) Selling, General, & Admin. Expense : kr0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Stenocare AS Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Stenocare AS's selling, general, & admin. expense for the three months ended in Mar. 2025 was kr0.00 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.00 Mil.


Stenocare AS Selling, General, & Admin. Expense Historical Data

The historical data trend for Stenocare AS's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stenocare AS Selling, General, & Admin. Expense Chart

Stenocare AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Selling, General, & Admin. Expense
Get a 7-Day Free Trial - - - - -

Stenocare AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Stenocare AS's Selling, General, & Admin. Expense

For the Drug Manufacturers - Specialty & Generic subindustry, Stenocare AS's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stenocare AS's Selling, General, & Admin. Expense Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stenocare AS's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Stenocare AS's Selling, General, & Admin. Expense falls into.


;
;

Stenocare AS Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stenocare AS  (OCSE:STENO) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Stenocare AS Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Stenocare AS's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Stenocare AS Business Description

Industry
Traded in Other Exchanges
N/A
Address
Nyholmsvej 4, Randers NØ, DNK, 8930
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The Company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The Company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway. It has an indoor production facility for the cultivation and production of medical cannabis at Randers, Denmark.

Stenocare AS Headlines

No Headlines